InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research
Publication on a Novel Hydrogel Formulation for the Treatment of Glaucoma Helps Validate InMed\'s Fully Integrated, Cannabinoid-based Business Model
CSE: IN OTCQB: IMLFF
VANCOUVER, March 6, 2018 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (CSE: IN; OTCQB:...
For more information, please visit
https://www.prnewswire.com/news-releases[...]tional-research-675960623.html
